Low price high purity 755037-03-7 Regorafenib (Synonyms: BAY 73-4506) in stock CAS NO.755037-03-7
- FOB Price: USD: 780.00-800.00 /Gram Get Latest Price
- Min.Order: 1 Gram
- Payment Terms: T/T,
- Available Specifications:
gram (1-5)Gramgram (5-10)Gram
- Product Details
Keywords
- 755037-03-7
- Regorafenib (Synonyms: BAY 73-4506)
- Low price high purity 755037-03-7 Regorafenib (Synonyms: BAY 73-4506)
Quick Details
- ProName: Low price high purity 755037-03-7 Rego...
- CasNo: 755037-03-7
- Molecular Formula: C??H??ClF?N?O?
- Appearance: powder
- Application: Regorafenib (BAY 73-4506) is a multi-t...
- DeliveryTime: 3-5 days after received the 100% payme...
- PackAge: by bottle
- Port: Wuhan
- ProductionCapacity: 10 Gram/Week
- Purity: >=99%
- Storage: 4°C, protect from light
- Transportation: By courier ( Fedex, UPS, DHL, EMS, SF ...
- LimitNum: 1 Gram
- Solvent:: DMSO : ≥ 260 mg/mL (538.50 mM)
Superiority
Low price high purity 755037-03-7 Regorafenib (Synonyms: BAY 73-4506) in stock
Regorafenib (BAY 73-4506) is a multi-targeted receptor tyrosine kinase inhibitor with IC50s of 13/4.2/46, 22, 7, 1.5 and 2.5 nM for VEGFR1/2/3, PDGFRβ, Kit, RET and Raf-1, respectively.
Molecular Weight |
482.82 |
||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Formula |
C??H??ClF?N?O? |
||||||||||||
CAS No. |
755037-03-7 |
||||||||||||
SMILES |
O=C(NC1=CC=C(C(C(F)(F)F)=C1)Cl)NC2=CC=C(OC3=CC(C(NC)=O)=NC=C3)C=C2F |
||||||||||||
Shipping |
Room temperature in continental US; may vary elsewhere. |
||||||||||||
Storage |
|
We have more than 10g stock at hand with very low price and with good quality and if you need more we can make Customized specifically for you.
Details
Wuhan Jonk Biological technology Co.,Ltd is a leading supplier of phytochemical reference standards and small molecule compound for regulatory filing and quality testing or early stage R&D. We are professional in extraction, synthesis and purification. With more than 5,000 products for sale, we serve the universal leading research institutes, universities, contract research organizations and large pharmaceutical and biotech companies sincerely .